U.S. pricing has been the bigegts issue of the year for drugmakers heavily exposed to the U.S. market.
This is how exposed European Big Pharma is to the U.S.
Related Posts
Spain rules out cyber attack – but what could have caused power cut?
The Spanish grid operator said the preliminary assessment suggests there was no cyber attack.
CASS: Injecting Object-Level Context for Advanced Open-vocabulary semantic segmentation
This paper was just accepted at CVPR 2025. In short, CASS is as an elegant solution to Object-Level Context in…
Trump administration keeps Biden’s tough rules for merger reviews
The Biden-era guidelines for antitrust reviews of mergers by the DOJ and FTC are widely disliked by corporations.